ClinicalTrials.gg
Status unknownNCT04123977TraumaThoraxUpdated Oct 21, 2019

Evaluation of Patient Analgesia After Bloc Serratus

An observational study in Thorax Traumas, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-10-21.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Thorax traumas are very common in severe traumatology, including road accidents, representing the second most frequent site (after head injury, according to the FIRST study). These thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung infections, atelectasis).

The national recommendations recommend the use of multi-modal analgesia with the use of regional loco anaesthesia for pain management and prevention of respiratory complications, including infectious complications. The loco-regional anaesthesia of choice is thoracic epidural or paravertebral block, but these techniques are not without risks, and are contraindicated in many situations (severe head trauma, patient under curative anticoagulation, pelvic trauma...).

The anterior Serratus block appears to be a quality localoregional anaesthesia in thoracic surgery, and a few cases in the literature have shown an interest in severe traumatology.

The investigators perform this anterior Serratus block almost systematically in patients with thoracic trauma in the Hautepierre surgical intensive care unit.

02

Conditions studied

  • Thorax Traumas

Browse trials for

Keywords

  • thorax trauma
  • head injury
  • Multi-modal analgesia
  • Paravertebral block
  • Thoracic epidural
  • Serratus Block
03

In context

Craniocerebral Trauma

264 studies on the registry are indexed under Craniocerebral Trauma; 45 are open to participants now.

This study's planned enrollment of 100 is below the median of 200 across 115 observational studies indexed under Craniocerebral Trauma.

Browse Craniocerebral Trauma studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 997 studies on the registry; 356 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019

Eligibility criteria

Inclusion criteria:

  • Adult patient (≥18 years old)
  • Gender (Male and Female)
  • Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019
  • Patient who has given his consent to the reuse of his data for the purposes of this research

Criteria for non-inclusion:

  • Patient who has expressed opposition to participating in the study
  • Impossibility of giving the subject informed information (difficulties in understanding the subject,...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Retrospective analysis of analgesia after Bloc serratus

    Time frame: Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined

07

Study locations

1 of 1 sites recruiting
  • Service de Réanimation chirurgicale_ Hôpital de Hautepierre
    Strasbourg, 67091, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04123977
Responsible party
Sponsor
First posted
Oct 11, 2019
Start date
Oct 1, 2019
Primary completion
Oct 2020 (estimated)
Completion
Oct 2020 (estimated)
Last update
Oct 21, 2019

Study contacts

Julien POTTECHER, MD, PhD
Contact
julien.pottecher@chru-strasbourg.fr
33 3 88 12 70 95
Kevin COGNE, MD
Contact
kevin.cogne@chru-strasbourg.fr
33 3.88 12 61 55
Julien POTTECHER, MD, PhD
study director · University Hospital, Strasbourg, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion